Status:
COMPLETED
A Continuous Glucose Monitor Based Insulin Bolus Calculator
Lead Sponsor:
Welldoc
Conditions:
Diabetes Mellitus, Type 2
Diabetes Mellitus, Type 1
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study examines the safety of an app-based insulin bolus calculator that utilizes glucose values from a continuous glucose monitor
Detailed Description
Individuals with type 1 diabetes and those with type 2 diabetes who are prescribed bolus insulin must decide on an insulin dose for any given meal. This dose is often based on what they are eating and...
Eligibility Criteria
Inclusion
- type 1 diabetes
- type 2 diabetes
- using Dexcom G6 CGM system
- injecting bolus insulin
Exclusion
- pregnancy,
- insulin pump use
Key Trial Info
Start Date :
July 5 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 28 2022
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT05229445
Start Date
July 5 2022
End Date
September 28 2022
Last Update
October 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern University
Chicago, Illinois, United States, 60611